EP0453555B1 - Vorratsbehälter für einen bestandteil einer medikamentenlösung - Google Patents

Vorratsbehälter für einen bestandteil einer medikamentenlösung Download PDF

Info

Publication number
EP0453555B1
EP0453555B1 EP19910900240 EP91900240A EP0453555B1 EP 0453555 B1 EP0453555 B1 EP 0453555B1 EP 19910900240 EP19910900240 EP 19910900240 EP 91900240 A EP91900240 A EP 91900240A EP 0453555 B1 EP0453555 B1 EP 0453555B1
Authority
EP
European Patent Office
Prior art keywords
bottle
capsule
neck
bottle according
transfer device
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
EP19910900240
Other languages
English (en)
French (fr)
Other versions
EP0453555A1 (de
Inventor
Gabriel Meyer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Becton Dickinson France SA
Original Assignee
Medicorp Holding SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medicorp Holding SA filed Critical Medicorp Holding SA
Publication of EP0453555A1 publication Critical patent/EP0453555A1/de
Application granted granted Critical
Publication of EP0453555B1 publication Critical patent/EP0453555B1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2089—Containers or vials which are to be joined to each other in order to mix their contents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/10—Bag-type containers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/1475—Inlet or outlet ports
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/2006—Piercing means
    • A61J1/201—Piercing means having one piercing end
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/202—Separating means
    • A61J1/2031—Separating means having openings brought into alignment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/202—Separating means
    • A61J1/2041—Separating means having removable plugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/2068—Venting means
    • A61J1/2072—Venting means for internal venting
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2096—Combination of a vial and a syringe for transferring or mixing their contents

Definitions

  • the present invention relates to a storage vial containing a medicinal substance and provided with a transfer device for transferring this substance directly, or after having mixed it with another substance, in another container, this vial comprising an open narrowed neck and the transfer device comprising a closure member at least partially engaged in this neck, at least during storage, in which the closure member consists of two elements: a first element constituted by a solid plug of elastomer, the diameter is substantially equal to that of the neck of the bottle and which is engaged in this neck to close it sealingly during storage, and a second element consisting of an elastomer O-ring whose outside diameter is substantially equal to that of the neck of the bottle and which is engaged in this neck.
  • Medicinal substances whether directly usable or whether they constitute the components of a mixture, are usually stored in containers which can either be flame-sealed glass ampoules or vials sealed with a stopper. shutter.
  • this liquid must be introduced into the storage bottle to come into contact with the solid or powdery component and for the dissolve.
  • the closure member must be pierced to allow the liquid to flow or pushed entirely inside the bottle so as to release the neck, or else partially pushed back so as to release a lateral opening allowing passage some cash.
  • a first problem posed by known bottles is that caused by the piercing of the closure member to allow the solvent to be transferred inside the bottle.
  • This piercing can tear elastomeric material from the plug usually used as a sealing member, and the torn particles can, in some cases, be injected into the body and cause serious disorders.
  • the present invention overcomes the drawbacks of known prior systems and eliminates all the risks associated with piercing a shutter member.
  • a second problem posed by known bottles is that of the waterproof barrier and the aseptic barrier.
  • the closure member must fulfill several functions and must meet several requirements both during storage and during use.
  • the obturation member During the use phase, it must constitute both a tight barrier and an aseptic barrier preventing in particular any bacterial penetration inside the bottle.
  • the obturation member During the use phase, the obturation member must maintain, in particular in the initial activation phase, an aseptic barrier to protect the contents of the bottle and free access to the interior of this bottle to allow the solvent penetration.
  • the present invention is designed to solve this problem by structuring the shutter member so that it can fulfill all of the functions defined above.
  • a third problem posed by known bottles is due to the fact that during the dissolution of the component by the solvent, large amounts of gas and in particular carbon dioxide can be released, which generates a significant overpressure in the bottle or in the container. of use.
  • this gas can be transferred into this container.
  • this gas must imperatively be evacuated, at least in part.
  • this device does not solve the first problem mentioned above since the activation is done by piercing or tearing off an elastomer membrane.
  • the present invention also makes it possible to solve this problem by providing means for evacuating the pressurized gas inside the storage bottle when the pulverulent solid substance is dissolved by the solvent.
  • the bottle is characterized in that the transfer device is constituted by a trocar with double conduit, the openings of which are axially offset with respect to each other, and in that one of these openings opens freely in said space formed between said first and said second element of the shutter member.
  • said first element is a lyophilization stopper comprising a solid upper part and a lower extension provided with lateral vents, this extension being designed to ensure prepositioning of the stopper on the neck of the bottle during the lyophilization of the substance. contained in this bottle.
  • the bottle comprises a capsule adapted over the neck of said bottle and movable axially between a storage position and an activated position, this capsule having a substantially cylindrical inner part comprising at least one shoulder serving as support to said second element of the shutter member, and the transfer device is integral with the inner part of the capsule.
  • Said interior opening opening into the space formed between said first and second elements can be formed in the wall of the interior part of the capsule and makes said space communicate with a central cavity of this capsule.
  • the transfer device is provided with at least one vent also opening into the space provided between said first element and said second element of the shutter member.
  • Said vent may include a calibrated orifice and be associated with a filter.
  • said filter is of the hydrophobic type.
  • Said vent can also be made in the bottom of the inner part of the capsule and opens into the central cavity of this capsule.
  • the storage bottle 10 is associated with a transfer device 11 which is adapted on the neck 12 of the bottle 10 containing a medicinal substance 13 in the powder state.
  • the neck 12 of the bottle 10 is substantially cylindrical and of reduced section compared to that of the body.
  • the transfer device 11 consists in this case of an elongated element 14 in the form of a trocar consisting of a double needle and of a closure member 15.
  • This closure member comprises a first element constituted by a solid plug made of elastomer 16a which is engaged in the neck and at a diameter slightly greater than the latter, and a second element 16b also engaged in the neck and which is constituted by an O-ring made of elastomer.
  • This device is protected by a cap 17 which covers the entire device and the free lower edge 18 of which bears against a shoulder 19 which provides the connection between the neck and the body of the bottle 10.
  • the elongated element 14 has two conduits axial, respectively 20 and 21, each provided with a first opening 20a, respectively 21a, designed to open inside the bottle, and a second opening 20b, respectively 21b, opening outside the bottle.
  • the elongate element 14 ends with a point 22 at its end external to the bottle. It will be noted that the orifices opening out inside the bottle, that is to say the openings 20a and 21a, are offset axially with respect to each other and that the openings 20b and 21b opening out are also axially offset from each other.
  • a capsule 23 secured to the closure member 15 is engaged over the neck 12 of the bottle and serves as a seat for the cap 17.
  • this capsule is secured to the elongated element 14. Furthermore, it serves as a support for the second element 16b of the shutter member 15.
  • the capsule 23 has an inner part 24, of substantially cylindrical and concave shape, arranged to be able to slide inside the neck 12 of the bottle, and an outer part 25 which passes over the rim 26 of this neck 12, in particular at when the device is brought from the storage position to the active position.
  • the annular part 27, which provides the connection between the internal part 24 and the external part 25, defines a shoulder 28 under which is placed the O-ring 29 which constitutes the second element 16b of the shutter member and which bears against the inner wall of the neck 12 to form an aseptic barrier during storage and a seal and an aseptic barrier during the activation phase.
  • FIG. 2 This phase is represented in particular by FIG. 2.
  • the protective cap 17 has been removed and the elongated element has been inserted inside a container 30 containing a liquid 31 intended to dissolve the powder 13 contained in the bottle 10.
  • the element elongated was used to pierce the closure cap 32 of the container 30.
  • the capsule 23 was pressed onto the neck 12 of the bottle 10, which had the effect of pushing the first element 16a of the organ of obturation 15 inside this bottle and to release the orifices 20a and 21a.
  • the liquid 31, contained in the container 30, flows through the axial duct 20 inside the bottle 10, and the air, initially contained in the bottle 10, or the gases generated by the reaction of the solvent 31 on the powder 13, are discharged through the axial channel 21 in the container 30.
  • the powder is a substance which reacts with the solvent by releasing a large amount of gas
  • the container is made of glass or of a material which withstands high overpressure.
  • the liquid 31 dissolves the powdery substance 13 and constitutes a solution liquid medicament which can then be transferred almost entirely into the container 30, after inversion of the assembly as shown in FIG. 3.
  • the transfer device makes it possible to connect two rigid bottles and that the transfer operation proper can be carried out in a sterile environment with a minimum risk of contamination.
  • the device makes it possible to transfer in two directions, that is to say from one bottle to another or vice versa, of any liquid substance.
  • the activation of the device is done in a simple way by sliding the transfer device associated with one of the bottles. The process can be stopped at any time.
  • Figs. 4 and 5 illustrate two storage bottles which differ essentially in that the first is intended to contain a lyophilisate 40 and the second a powder 41.
  • This difference in destination results in a difference in construction: the first bottle comprises a closure member 15, the first element 16a of which is a lyophilization plug as shown in perspective in FIG. 6, and the second bottle comprises a closure member 15, the first element 16a of which is a simple stopper as shown in perspective in FIG. 7.
  • the transfer device 11 consists of a needle 42 and the shutter member 15. It is, as for the previous embodiment, protected by a cap 17. During storage, this cap 17 is linked to the bottle 10 by a tamper-evident label 43.
  • the closure member 15 consists of said first element 16a defined above and the second element 16b which is again an elastomer O-ring located between the internal surface of the neck 12 of the bottle and the internal part 24 of the capsule 23
  • This inner part has a central cavity 44 and is equipped, in the area between the first element 16a and the second element 16b of the shutter member 15, with large openings 45.
  • the inner part 24 of the capsule 23 is coupled to said first element 16a of the shutter member. This is to prevent this element from falling inside the bottle when the latter is activated.
  • the bottom 46 of the capsule is provided with vents 47 whose role will be explained below.
  • a filter 48 is fixed inside the bottom 46 and constitutes the compulsory passage between the inside of the bottle and the central channel of the needle 42.
  • This needle is integral with a needle-holder tip 49 and is fixed on a cone 50 secured to the bottom 46 of the capsule.
  • the needle 42 is protected by a tubular element 51 which is engaged by its annular base 52 with a bent section, on the end of the capsule 23.
  • the operator After having pricked the needle 42 in a bottle or a pocket containing a liquid solvent (not shown), pushes the capsule back to engage it fully in the neck of the bottle.
  • the first element 16a of the closure member 15 penetrates entirely inside the bottle without however falling into this bottle since it is retained by the end of the inner part 24 of the capsule 23.
  • the liquid crosses the channel central of the needle, the central cavity of the capsule, the openings 45 and enters the vial.
  • the dissolution of the lyophilisate 40 or of the powder 41 can, in certain cases, lead to a strong release of gas, in particular carbon dioxide, which can escape through the large openings 45 and the vents 47 without disturbing the flow of the liquid or cause excessive pressure in the bottle.
  • the element 16a represented by FIG. 6 has a solid upper part 60 and a mouthpiece 61 which has a cross section in the form of a cross providing lateral vents 62 which allow the evacuation of gases when the element 16a is prepositioned on the neck of the bottle during the operation lyophilization.
  • the element 16a illustrated by FIG. 7 corresponds to the solid upper part of the element shown in FIG. 6.
  • the prepositioning tip required for freeze-drying can be removed.
  • Figs. 8 and 9 illustrate two embodiments, sectional views of the closure member of the bottle according to the invention.
  • Fig. 8 shows a shutter member at all points identical to that described above with reference to FIG. 5. However, the shutter member of FIG. 5 is shown in the storage position while that of FIG. 8 is shown in the activated position.
  • the first element 16a of the closure member is connected to the lower end of the interior part 24 of the capsule 23, which prevents this element from falling inside the bottle.
  • the bottom of the central cavity 44 of the capsule is closed by a filter 48.
  • a recess 70 formed at the bottom of this central cavity communicates by a conduit 71 with an annular groove 72 to constitute said vents whose role is has been described above.
  • the embodiment shown in FIG. 9 differs somewhat in that the vents 47 are designed differently.
  • the central cavity 44 communicates through channels 80 with an annular groove 81 which is separated from an annular groove 82 by an annular filter 83 which has the property of being hydrophobic.
  • the groove 82 communicates with the outside via a channel 84 which has a calibrated diameter. The diameter of this channel is determined in such a way that the overpressure generated for example by the generation of gas at the time of the dissolution of the powder by the solvent, can be evacuated slowly.
  • Channel 84 defines a calibrated leak.
  • Fig. 10 illustrates another use of the bottle according to the invention.
  • the bottle 10, the closure member 15 and the capsule 23 are identical in all respects to those described above.
  • the capsule is adapted to receive a needle 90 intended to pierce a stopper 91 of a flexible bottle 92 containing a liquid solvent.
  • Needle 90 is advantageously made of synthetic material and comprises a central channel 93 and a lateral opening 94 through which the liquid intended to dissolve the powdery medicinal substance or in the state of lyophilisate initially contained in the bottle can flow.
  • the capsule 23 is provided with vents 47 allowing the evacuation of the overpressure gases contained in the bottle.
  • Fig. 11 illustrates another use of the bottle according to the invention.
  • This bottle is identical in all respects to that shown in fig. 5.
  • the needle 42 has been inserted into the closure cap 100 of a flexible infusion bag 101 equipped with an infusor 102.
  • This infusion bag contains the solvent which is intended to be introduced into the bottle 10 to dissolve the powder or lyophilisate it contains before the solution is poured back into the infusion bag.
  • Fig. 12 illustrates a form of use of the bottle in which the capsule 23 is arranged to allow coupling by screwing of an end piece 103 of a bottle 104 containing a liquid solvent.
  • This end fitting contains a shutter 105 which provides an axial conduit 106 for the passage of the liquid in the enlarged zone 107 of the neck 108 of the bottle 104.
  • the first element 16a of the closure member 15 is fixed to the end of the capsule 23 which has at least one opening 45 allowing the passage of the liquid.
  • Fig. 13 illustrates another embodiment in which the capsule 23 is equipped with a tip 110 of the Luer-Lock type.
  • Figs. 14 and 15 illustrate two uses of the bottle according to the invention when the latter is connected to syringes.
  • a pre-filled syringe 120 of a type known per se, is coupled to a bottle, the capsule of which is provided with a tip of the Luer-Lock type as shown in FIG. 13.
  • a traditional syringe 130 is coupled to a connection endpiece 131 provided with a Luer cone, integral with the capsule 23.
  • the bottle illustrated in fig. 16 comprises a capsule, the part of which faces the inside of the bottle 10 is extended by a stud 140 which serves as a pusher for pushing said first element 16a from the closure member 15, when the bottle is brought from the storage position. in the activation position.
  • said first element 16a of the closure member 15 is not linked to the capsule as was the case in most of the previous embodiments.
  • the second element 16b of the shutter member performs a dual function. During storage, this element acts as a protective barrier against bacteria and prevents contamination of the substance stored inside the bottle. During use, this second element constitutes a seal which prevents an undesirable flow of the drug solution between the capsule and the interior wall of the neck of the bottle.

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Package Specialized In Special Use (AREA)

Claims (10)

  1. Vorratsbehälter, der eine heilkräftige Substanz enthält und mit einer Umfüllvorrichtung versehen ist, um diese Substanz unmittelbar oder nach deren Mischung mit einer anderen Substanz in ein anderes Behältnis umzufüllen, wobei dieser Behälter einen offenen engeren Hals besitzt, und die Umfüllvorrichtung mit einem Verschlußorgan versehen ist, das mindestens während der Aufbewahrung in diesen Hals teilweise eingeführt ist, wobei das Verschlußorgan (15) aus zwei Teilen besteht: aus einem ersten Teil (16a), das aus einem massiven Stopfen aus einem Elastomer gebildet ist, dessen Durchmesser in etwa dem Durchmesser des Halses (12) des Behälters (10) entspricht, und der in den Hals eingeführt ist, um ihn während der Aufbewahrung dicht zu verschließen, und aus einem zweiten Teil (16b), das von einem Rundschnurdichtring aus einem Elastomer gebildet ist, dessen Durchmesser in etwa dem Durchmesser des Halses (12) des Behälters (10) entspricht und der in den Hals eingeführt ist,
    dadurch gekennzeichnet, daß
    die Umfüllvorrichtung (11) aus einer Dreikantnadel mit doppelter Leitung (20,21) besteht, deren Öffnungen gegeneinander axial versetzt sind, und daß eine dieser Öffnungen in den Raum zwischen dem ersten Teil (16a) und dem zweiten Teil (16b) des Verschlußorganes (15) frei mündet.
  2. Behälter nach Anspruch 1,
    dadurch gekennzeichnet, daß
    das erste Teil (16a) ein Stopfen für die Lyofilisierung ist, der aus einem massiven oberen Teil (60) und aus einer unteren Verlängerung (62) mit seitlichen Entlüftungen besteht, wobei diese Verlängerung ausgelegt ist, um eine Vorpositionierung des Stopfens auf dem Hals (12) des Behälters während der Lyofilisierung der Substanz, die in dem Behälter enthalten ist, sicherzustellen.
  3. Behälter nach Anspruch 1,
    dadurch gekennzeichnet, daß
    er eine Kapsel (23) enthält, die über dem Hals (12) des Behälters eingepaßt und zwischen einer Position für die Aufbewahrung und einer Gebrauchsstellung axial beweglich ist, wobei diese Kapsel ein inneres Teil (24) besitzt, das in etwa zylindrisch ist, mit mindestens einem Ansatz als Abstützung für das zweiten Teil (16b) des Verschlußorganes (15).
  4. Behälter nach Anspruch 3,
    dadurch gekennzeichnet, daß
    die Umfüllvorrichtung (11) mit dem inneren Teil (24) der Kapsel (23) fest verbunden ist.
  5. Behälter nach Anspruch 1,
    dadurch gekennzeichnet, daß
    die Öffnung, die in den Raum zwischen dem ersten Teil (16a) und dem zweiten Teil (16b) mündet, in der Wandung des inneren Teiles (24) der Kapsel (23) ausgeführt ist und den Raum mit einem mittleren Hohlraum (44) der Kapsel verbindet.
  6. Behälter nach Anspruch 1,
    dadurch gekennzeichnet, daß
    die Umfüllvorrichtung (11) mit mindestens einer Entlüftung (47) versehen ist, die ebenfalls in dem Raum zwischen dem ersten Teil (16a) und dem zweiten Teil (16b) des Verschlußorganes (15) mündet.
  7. Behälter nach Anspruch 6,
    dadurch gekennzeichnet, daß
    die Entlüftung eine kalibrierte Öffnung (84) aufweist.
  8. Behälter nach Anspruch 6,
    dadurch gekennzeichnet, daß
    die Entlüftung mit einem Filter (48) verbunden ist.
  9. Behälter nach Anspruch 8,
    dadurch gekennzeichnet, daß
    der Filter (48) einer wasserabweisenden Ausführung entspricht.
  10. Behälter nach Anspruch 6,
    dadurch gekennzeichnet, daß
    die Entlüftung am Boden des inneren Teiles (24) der Kapsel (23) angeordnet ist und in dem mittleren Hohlraum (44) der Kapsel (23) mündet.
EP19910900240 1989-11-13 1990-11-10 Vorratsbehälter für einen bestandteil einer medikamentenlösung Expired - Lifetime EP0453555B1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH4081/89 1989-11-13
CH408189 1989-11-13

Publications (2)

Publication Number Publication Date
EP0453555A1 EP0453555A1 (de) 1991-10-30
EP0453555B1 true EP0453555B1 (de) 1993-10-06

Family

ID=4269470

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19910900240 Expired - Lifetime EP0453555B1 (de) 1989-11-13 1990-11-10 Vorratsbehälter für einen bestandteil einer medikamentenlösung

Country Status (9)

Country Link
US (1) US5358501A (de)
EP (1) EP0453555B1 (de)
JP (1) JPH0659302B2 (de)
AT (1) ATE95415T1 (de)
CA (1) CA2045408A1 (de)
DE (1) DE69003805T2 (de)
DK (1) DK0453555T3 (de)
ES (1) ES2046039T3 (de)
WO (1) WO1991007160A1 (de)

Families Citing this family (80)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5613291A (en) * 1995-01-25 1997-03-25 Becton, Dickinson And Company Method for providing a sterility seal in a medicinal storage bottle
US5746724A (en) * 1995-04-13 1998-05-05 Advanced Cytometrix, Inc. Aspiration needle apparatus incorporating its own vacuum and method and adapter for use therewith
US5902280A (en) * 1995-04-13 1999-05-11 Advanced Cytometrix, Inc. Aspiration needle apparatus incorporating its own vacuum and method and adapter for use therewith
US5653694A (en) * 1995-04-13 1997-08-05 Advanced Cytometrix, Inc. Aspiration needle apparatus incorporating its own vacuum and method and adapter for use therewith
EP0820318A4 (de) * 1995-04-13 1998-10-14 Advanced Cytometrix Inc Aspirationsnadel mit eigener vakuumquelle und methode und adapter zu ihrem gebrauch
US5685845A (en) * 1995-07-11 1997-11-11 Becton, Dickinson And Company Sterile resealable vial connector assembly
US5702019A (en) * 1995-09-27 1997-12-30 Becton Dickinson France S.A. Vial having resealable membrane assembly activated by a medical delivery device
CA2185494A1 (en) 1995-09-27 1997-03-28 Jean-Pierre Grimard Resealable vial with connector assembly having a membrane and pusher
US6003702A (en) * 1995-09-27 1999-12-21 Becton Dickinson France, S.A. Vial with resealable connector assembly having a membrane and a multi-configuration fluid access device
WO1997039720A1 (en) 1996-04-22 1997-10-30 Abbott Laboratories Container closure system
US5871110A (en) * 1996-09-13 1999-02-16 Grimard; Jean-Pierre Transfer assembly for a medicament container having a splashless valve
US5785701A (en) * 1996-09-17 1998-07-28 Becton Dickinson And Company Sterile vial connector assembly for efficient transfer of liquid
CA2211629A1 (en) 1996-09-17 1998-03-17 Bernard Sams Vial connector assembly for a medicament container
US5873872A (en) 1996-09-17 1999-02-23 Becton Dickinson And Company Multipositional resealable vial connector assembly for efficient transfer of liquid
US5819964A (en) * 1996-09-27 1998-10-13 Becton Dickinson And Company Lyophilization closure assembly for a medicament container for use during a lyophilization process
US6036680A (en) * 1997-01-27 2000-03-14 Baxter International Inc. Self-priming solution lines and a method and system for using same
US5954104A (en) 1997-02-28 1999-09-21 Abbott Laboratories Container cap assembly having an enclosed penetrator
US5924584A (en) * 1997-02-28 1999-07-20 Abbott Laboratories Container closure with a frangible seal and a connector for a fluid transfer device
MY125870A (en) 1997-07-25 2006-08-30 Alza Corp Osmotic delivery system flow modulator apparatus and method
JPH11104215A (ja) * 1997-08-12 1999-04-20 Becton Dickinson Fr Sa ガラス瓶コネクタアセンブリ
US5925029A (en) * 1997-09-25 1999-07-20 Becton, Dickinson And Company Method and apparatus for fixing a connector assembly onto a vial with a crimp cap
US6090093A (en) * 1997-09-25 2000-07-18 Becton Dickinson And Company Connector assembly for a vial having a flexible collar
DE69832766T2 (de) 1997-09-25 2006-09-21 Becton Dickinson France S.A. Verbinder mit Verriegelungsring für eine Phiole
US6213994B1 (en) 1997-09-25 2001-04-10 Becton Dickinson France, S.A. Method and apparatus for fixing a connector assembly onto a vial
US6071270A (en) 1997-12-04 2000-06-06 Baxter International Inc. Sliding reconstitution device with seal
US6003566A (en) * 1998-02-26 1999-12-21 Becton Dickinson And Company Vial transferset and method
US6681946B1 (en) 1998-02-26 2004-01-27 Becton, Dickinson And Company Resealable medical transfer set
US6382442B1 (en) 1998-04-20 2002-05-07 Becton Dickinson And Company Plastic closure for vials and other medical containers
US6957745B2 (en) 1998-04-20 2005-10-25 Becton, Dickinson And Company Transfer set
US6378714B1 (en) 1998-04-20 2002-04-30 Becton Dickinson And Company Transferset for vials and other medical containers
US6904662B2 (en) 1998-04-20 2005-06-14 Becton, Dickinson And Company Method of sealing a cartridge or other medical container with a plastic closure
US6209738B1 (en) 1998-04-20 2001-04-03 Becton, Dickinson And Company Transfer set for vials and medical containers
US6113583A (en) 1998-09-15 2000-09-05 Baxter International Inc. Vial connecting device for a sliding reconstitution device for a diluent container
US20050137566A1 (en) 2003-12-23 2005-06-23 Fowles Thomas A. Sliding reconstitution device for a diluent container
AR021220A1 (es) 1998-09-15 2002-07-03 Baxter Int DISPOSITIVO DE CONEXIoN PARA ESTABLECER UNA COMUNICACIoN FLUíDA ENTRE UN PRIMER RECIPIENTE Y UN SEGUNDO RECIPIENTE.
US6234196B1 (en) * 1999-02-19 2001-05-22 Ultradent Products, Inc. Mixing adaptor and system
DE60023361T2 (de) 1999-12-21 2006-04-27 Alza Corp., Mountain View Ventil für osmotische vorrichtungen
US6503240B1 (en) 2000-01-24 2003-01-07 Brocco Diagnostics, Inc. Vial access adapter
US6544246B1 (en) 2000-01-24 2003-04-08 Bracco Diagnostics, Inc. Vial access adapter and vial combination
US6832994B2 (en) * 2000-01-24 2004-12-21 Bracco Diagnostics Inc. Table top drug dispensing vial access adapter
US7799009B2 (en) * 2000-01-24 2010-09-21 Bracco Diagnostics Inc. Tabletop drug dispensing vial access adapter
US6139534A (en) * 2000-01-24 2000-10-31 Bracco Diagnostics, Inc. Vial access adapter
AU2003217677A1 (en) * 2002-02-25 2003-09-09 Mitali Dutt Probe-activated medicament injector device
US7086431B2 (en) * 2002-12-09 2006-08-08 D'antonio Consultants International, Inc. Injection cartridge filling apparatus
US7731947B2 (en) 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
ES2397833T3 (es) 2003-03-05 2013-03-11 Csl Behring Gmbh Dispositivo de transferencia
DE502004005171D1 (de) 2003-03-06 2007-11-22 Csl Behring Gmbh Transfervorrichtung, insbesondere für medizinische Fluids
US7261698B2 (en) * 2003-04-24 2007-08-28 Sherwood Services Ag Transfer needle safety apparatus
US7641851B2 (en) 2003-12-23 2010-01-05 Baxter International Inc. Method and apparatus for validation of sterilization process
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
EP1859773B1 (de) * 2005-03-15 2013-04-24 Ajinomoto Co., Inc. Medizin-transfer-vorrichtung
EP2540276B1 (de) 2006-05-25 2016-03-16 Bayer Healthcare LLC Verfahren zur Herstellung einer Rekonstitutionsvorrichtung
KR101106510B1 (ko) 2006-05-30 2012-01-20 인타르시아 세라퓨틱스 인코포레이티드 투피스, 내부채널 삼투압 전달 시스템 유동 조절기
AU2007284759B2 (en) 2006-08-09 2010-10-28 Intarcia Therapeutics, Inc. Osmotic delivery systems and piston assemblies
US8770441B2 (en) 2007-03-27 2014-07-08 International Packaging Innovations, Llc Multiple channel single spike for a liquid dispensing system
US8177096B2 (en) * 2007-03-27 2012-05-15 International Packaging Innovations, Llc Bag cooler employing a multi-spike adapter and converter
RU2440097C2 (ru) 2007-04-23 2012-01-20 Интарсия Терапьютикс, Инк. Способ лечения диабета ii типа и ожирения, осмотическое устройство для доставки и способ его изготовления
US8221382B2 (en) * 2007-08-01 2012-07-17 Hospira, Inc. Medicament admixing system
CA2646261A1 (en) 2007-12-14 2009-06-14 Tyco Healthcare Group Lp Blood collection device with tube retaining structure
DE102008003105A1 (de) * 2008-01-01 2009-07-02 Lts Lohmann Therapie-Systeme Ag Einweginjektor mit handbetätigbarem Kolben und einem Zweikammersystem
DK2240155T3 (da) 2008-02-13 2012-09-17 Intarcia Therapeutics Inc Indretninger, formuleringer og fremgangsmåder til levering af flere gavnlige midler
DE102008054128A1 (de) * 2008-10-31 2010-06-10 Lts Lohmann Therapie-Systeme Ag Injektor und Zwei-Kammer-System mit abdichtendem Behälteradapter
US8356644B2 (en) * 2009-08-07 2013-01-22 Medtronic Minimed, Inc. Transfer guard systems and methods
EP3735944A1 (de) 2009-09-28 2020-11-11 Intarcia Therapeutics, Inc. Schnelle initiierung und/oder beendigung der verabreichung substantiell stabiler arzneimittel
US8721612B2 (en) 2010-12-17 2014-05-13 Hospira, Inc. System and method for intermixing the contents of two containers
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
CN103458853A (zh) * 2011-03-31 2013-12-18 松下电器产业株式会社 药剂移注针及药剂移注方法
WO2013055392A2 (en) 2011-10-03 2013-04-18 Hospira, Inc. System and method for mixing the contents of two containers
WO2014110242A1 (en) * 2013-01-10 2014-07-17 International Packaging Innovations, Llc Multiple channel single spike for a liquid dispensing system
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
MA44390A (fr) 2015-06-03 2019-01-23 Intarcia Therapeutics Inc Systèmes de mise en place et de retrait d'implant
WO2017200943A1 (en) 2016-05-16 2017-11-23 Intarcia Therapeutics, Inc. Glucagon-receptor selective polypeptides and methods of use thereof
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
ES2646920B1 (es) * 2016-06-15 2018-07-23 Industrias Somec Y Ribas, S.L. Dispositivo dispensador de líquidos
IL267736B2 (en) 2017-01-03 2024-03-01 Intarcia Therapeutics Inc Methods involving continuous administration of a GLP-1 receptor agonist and co-administration of a drug
US10596591B2 (en) * 2017-01-04 2020-03-24 Red Devil Inc. Material dispensing system and method
USD933219S1 (en) 2018-07-13 2021-10-12 Intarcia Therapeutics, Inc. Implant removal tool and assembly
US12054334B2 (en) 2021-11-19 2024-08-06 Red Devil, Inc. Sausage package dispensing system, device and method

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB528471A (en) * 1939-05-08 1940-10-30 Paul Dux Improvements in or relating to ampoules or like devices
US3033202A (en) * 1955-10-07 1962-05-08 Baxter Laboratories Inc Parenteral solution equipment and method of using same
US3857392A (en) * 1969-06-04 1974-12-31 Ims Ltd Intravenous container with dislodgeable septum and dislodging piercer
US3858580A (en) * 1969-06-04 1975-01-07 Ims Ltd Intravenous container mixing assembly
US3674028A (en) * 1969-06-04 1972-07-04 Ims Ltd Multi-mix
US3739779A (en) * 1970-04-28 1973-06-19 Medical Electroscience & Pharm Hypodermic syringe and needle construction
AR205565A1 (es) * 1974-04-29 1976-05-14 Abbott Lab Unidad de almacenamiento y transferencia para un aditivo particularmente aplicable a la transferencia de medicamentos
US3977555A (en) * 1974-05-07 1976-08-31 Pharmaco, Inc. Protective safety cap for medicament vial
US4381776A (en) * 1980-06-20 1983-05-03 Haemonetics Corporation Anticoagulant dispensing apparatus and method of use
US4543101A (en) * 1984-03-28 1985-09-24 Adria Laboratories, Inc. Valve device to aid in reconstituting injectable powders
US4610374A (en) * 1984-10-29 1986-09-09 Dougherty Brothers Company Apparatus for mixing flowable materials in sealed containers
US4834152A (en) * 1986-02-27 1989-05-30 Intelligent Medicine, Inc. Storage receptacle sealing and transfer apparatus
US4865189A (en) * 1988-08-24 1989-09-12 Alcon Laboratories, Inc. Device for storage, mixing, and dispensing of two different fluids

Also Published As

Publication number Publication date
ES2046039T3 (es) 1994-01-16
JPH0659302B2 (ja) 1994-08-10
DK0453555T3 (da) 1994-01-31
DE69003805T2 (de) 1994-05-19
ATE95415T1 (de) 1993-10-15
US5358501A (en) 1994-10-25
JPH04500331A (ja) 1992-01-23
DE69003805D1 (de) 1993-11-11
EP0453555A1 (de) 1991-10-30
CA2045408A1 (fr) 1991-05-14
WO1991007160A1 (fr) 1991-05-30

Similar Documents

Publication Publication Date Title
EP0453555B1 (de) Vorratsbehälter für einen bestandteil einer medikamentenlösung
EP0403626B1 (de) Aufbewahrungs- und umfüllflasche zum aufbewahren von zwei bestandteilen einer heilkräftigen substanz
EP1226077B1 (de) Einsatzbereite verbindungsvorrichtung
EP0462255B1 (de) Aufbewahrungs- und umfüllflasche mit doppelter kammer
EP0684846B1 (de) Vorgefüllte spritze zur bewahrung und abgabe eines sterilen flüssigen arzneimittels
EP0406374B1 (de) Aufbewahrungs- und umfüllflasche zum aufbewahren von zwei bestandteilen einer heilkräftigen substanz
EP1694269B1 (de) Kappe für die sichere verpackng einer medizinflasche
EP1115361B1 (de) Verbindungsvorrichtung zwischen behälter und inhalt und gebrauchsfertige anordungen die eine solche vorrichtung enthalten
EP0448656B1 (de) Länglicher behälter mit zwei getrennten kammern auf der gleichen längsachse
EP1079789B1 (de) Ampulle zur aufnahme einer medizinischen flüssigkeit
EP1349530A1 (de) Ampulle zur aufnahme und zum transferieren einer medizinischen flüssigkeit oder eines pulvers
WO1999036029A1 (fr) Dispositif de confinement etanche, pour la connexion d'un recipient et d'un moyen de delivrance d'une matiere
EP1239808A1 (de) Verbindungsvorrichtung zwischen behälter und inhalt und gebrauchsfertige anordungen die eine solche vorrichtung enthalten
FR2717086A1 (fr) Dispositif de seringue pour le mélange de deux composés.
CH666870A5 (fr) Dispositif de conditionnement de substances liquides ou liquides et solides.
WO1997020536A1 (fr) Dispositif pour la preparation d'une solution medicamenteuse reconstituee a partir de deux composants
EP1034772B1 (de) Vorrichtung zum Übertragen einer in einem Flacon enthaltenen Substanz in einen Beutel der eine Lösung enthält
FR2767514A1 (fr) Flacon melangeur mettant en contact deux composants isoles avant leur prelevement et leur injection a l'aide d'une seringue
FR2708469A1 (fr) Dispositif de seringue pour le mélange de deux composés.
CA2045501A1 (fr) Contenant de forme allongee comportant deux compartiments separes, l'un etant le prolongement de l'autre
FR2853830A1 (fr) Capuchon de transfert a moyen d'etancheite
FR2715311A1 (fr) Dispositif de seringue pour le mélange de deux composés.
FR2714294A1 (fr) Dispositif de seringue pour le mélange de deux composés.

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19910622

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL SE

17Q First examination report despatched

Effective date: 19920525

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL SE

REF Corresponds to:

Ref document number: 95415

Country of ref document: AT

Date of ref document: 19931015

Kind code of ref document: T

REF Corresponds to:

Ref document number: 69003805

Country of ref document: DE

Date of ref document: 19931111

ITF It: translation for a ep patent filed
REG Reference to a national code

Ref country code: CH

Ref legal event code: PUE

Owner name: BECTON DICKINSON FRANCE S.A.

REG Reference to a national code

Ref country code: GB

Ref legal event code: 732E

GBT Gb: translation of ep patent filed (gb section 77(6)(a)/1977)

Effective date: 19931115

EPTA Lu: last paid annual fee
BECA Be: change of holder's address

Free format text: 931006 S.A. *BECTON DICKINSON FRANCE:11 RUE ARISTIDE BERGES, F-38800 LE PONT-DE-CLAIX

BECH Be: change of holder

Free format text: 931006 S.A. *BECTON DICKINSON FRANCE

REG Reference to a national code

Ref country code: FR

Ref legal event code: TP

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2046039

Country of ref document: ES

Kind code of ref document: T3

REG Reference to a national code

Ref country code: GR

Ref legal event code: FG4A

Free format text: 3009935

Ref country code: DK

Ref legal event code: T3

NLS Nl: assignments of ep-patents

Owner name: BECTON DICKINSON FRANCE S.A. TE LE PONT-DE-CLAIX,

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

ITPR It: changes in ownership of a european patent

Owner name: CESSIONE;BECTON DICKINSON FRANCE S.A.

26N No opposition filed
EAL Se: european patent in force in sweden

Ref document number: 91900240.2

REG Reference to a national code

Ref country code: GB

Ref legal event code: IF02

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GR

Payment date: 20051129

Year of fee payment: 16

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20070604

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: CH

Payment date: 20081125

Year of fee payment: 19

Ref country code: DK

Payment date: 20081125

Year of fee payment: 19

Ref country code: LU

Payment date: 20081204

Year of fee payment: 19

Ref country code: NL

Payment date: 20081124

Year of fee payment: 19

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: AT

Payment date: 20081021

Year of fee payment: 19

Ref country code: ES

Payment date: 20081126

Year of fee payment: 19

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: SE

Payment date: 20081128

Year of fee payment: 19

Ref country code: IT

Payment date: 20081126

Year of fee payment: 19

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20081117

Year of fee payment: 19

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20081223

Year of fee payment: 19

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20081128

Year of fee payment: 19

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: BE

Payment date: 20090128

Year of fee payment: 19

REG Reference to a national code

Ref country code: CH

Ref legal event code: PCAR

Free format text: CABINET ROLAND NITHARDT CONSEILS EN PROPRIETE INDUSTRIELLE S.A.;Y-PARC RUE GALILEE;1400 YVERDON-LES-BAINS (CH)

BERE Be: lapsed

Owner name: S.A. *BECTON DICKINSON FRANCE

Effective date: 20091130

REG Reference to a national code

Ref country code: NL

Ref legal event code: V1

Effective date: 20100601

EUG Se: european patent has lapsed
REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

REG Reference to a national code

Ref country code: DK

Ref legal event code: EBP

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20091110

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST

Effective date: 20100730

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20091110

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20091130

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20091130

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20091130

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20091130

Ref country code: NL

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20100601

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20100601

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20091110

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20091130

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20091110

REG Reference to a national code

Ref country code: ES

Ref legal event code: FD2A

Effective date: 20110408

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20091110

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20091111

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20110328

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20091111